Alon Kedem Selected Research

Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)

6/2013

What is the optimal threshold of serum Anti-Müllerian hormone (AMH) necessary for IVM treatments?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alon Kedem Research Topics

Disease

4	COVID-19 01/2023 - 01/2021
1	Premature Birth (Birth, Premature) 01/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2021
1	Preterm Premature Rupture of the Membranes 01/2021
1	Infertility (Sterility) 12/2020
1	Neoplasms (Cancer) 05/2018
1	Morbid Obesity 12/2014
1	Hematologic Diseases (Blood Diseases) 07/2014
1	Ovarian Hyperstimulation Syndrome 04/2014
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 06/2013
1	Stillbirth 12/2010
1	Liver Diseases (Liver Disease) 05/2005

Drug/Important Bio-Agent (IBA)

2	BNT162 VaccineIBA 01/2023 - 01/2022
2	VaccinesIBA 01/2022 - 01/2022
2	SuspensionsIBA 01/2021 - 12/2020
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 04/2014
1	Hormones (Hormone)IBA 06/2013
1	Prothrombin (Factor II)IBA 12/2010
1	factor V LeidenIBA 12/2010
1	EnzymesIBA 05/2005

Therapy/Procedure

1	Cesarean Section (Caesarean Section) 01/2021
1	Tissue and Organ Harvesting 05/2018
1	Bariatric Surgery 12/2014
1	Therapeutics 07/2014
1	Transplantation 05/2005